- Home
- News
News & Features
Brains Bioceutical Corp. is pleased to announce the completion of its US$30m Capital Raise
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
October 5, 2022
Through its wholly owned subsidiary BSPG Laboratories, Brains Bio’s new facility is set to become a global research center for cannabinoid research, testing, and commercialization
Brains Bioceutical Appoints Former Executive Director of Glaxosmithkline Bill Purves As CCO
April 19, 2022
This announcement comes following the company’s previous appointment of former Bio Gen Managing Director as President of Brains Bio VANCOUVER, BC and UNITED KINGDOM, April 19, 2022 /PRNewswire/ – Bill
Brains Bioceutical Appoints Former Managing Director and SVP of Biogen Terry O’Regan as President
April 15, 2022
Terry O’Regan brings over 20 years of senior management experience pioneering market, product, and business development. VANCOUVER, BC and UNITED KINGDOM, April 4, 2022 /CNW/ – Terry O’Regan’s strong track record in
Brains Bio Three Year Anniversary
March 7, 2022
On March 4, Brains Bioceutical celebrated its three-year anniversary as a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs). When you are immersed in an
Brains to provide EU-GMP CBD API for Brazils first medical approved cannabis product
